GlobeNewsWire
28 Sept 2026, 09:47 UTC · 1h ago
Verdict
Headline leans bearish. We score CAPR −1.00 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish · 1 new · 2 priced in
An FDA advisory committee voted 9-3 that available evidence did not support the efficacy of Deramiocel for treating DMD-associated cardiomyopathy.
Priced inreported on July 30, 2026
So whatThe failure of the lead product candidate significantly reduces the company's projected peak sales and long-term valuation multiple.
More negative than 98% of claims this week
Continue reading
5 related stories
More negative than 94% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
The FDA raised concerns that Capricor made post-hoc changes to its statistical analysis plan for the primary endpoint, PUL 2.0, before unblinding the database.
Priced inFDA briefing documents released July 27, 2026
More negative than 90% of claims this week
Capricor Therapeutics is being sued for securities fraud regarding alleged misstatements about Deramiocel clinical data and its Biologics License Application.
Newpress release dated Sept 28, 2026
More negative than 77% of claims this week
Which stocks this story touches
More negative than 94% of ticker scores this week
The company is facing a securities fraud class action lawsuit following a massive stock drop and FDA concerns over clinical data integrity.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
3h ago
—
CAPR hasn't traded since this ran. Last close $8.36 (Sep 25); the reaction starts at the next open.
CAPR chart →
